Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease

Lancet

Volumn 351, Issue 9106, 1998, Pages 884-

  Lieberman, Andrew P ^a   Robitaille, Yves ^b   Trojanowski, John Q ^b   Dickson, Dennis W ^b   Fischbeck, Kenneth H ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; POLYGLUTAMIC ACID;

CELL NUCLEUS INCLUSION BODY; DEGENERATIVE DISEASE; HUMAN; NERVE DEGENERATION; PRIORITY JOURNAL; SHORT SURVEY; TRINUCLEOTIDE REPEAT;

EID: 0032554551     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)70296-8     Document Type: Article

References (5)

1. 1 Lunkes A, Mandel J-L. Polyglutamines, nuclear inclusions and neurodegeneration. Nat Med 1997; 3: 1201-02.
2. 2 Haltia M, Somer H, Palo J, Johnson WG. Neuronal intranuclear inclusion disease in identical twins. Ann Neurol 1984; 15: 316-21.
3. 3 Munoz-Garcia D, Ludwin SK. Adult-onset neuronal intranuclear hyaline inclusion disease. Neurology 1986; 36: 785-90.
4. 4 Schuffler MD, Bird TD, Sumi SM, Cook A. A familial neuronal disease presenting as intestinal pseudoobstrution. Gastroenterology 1978; 75: 889-98.
5. 5 Trottier Y, Lutz Y, Stevanin G, et al. Polyglutamine expansion as a pathologic epitope in Huntington's disease and four dominant ataxias. Nature 1995; 378: 403-06.